EANS-News: Epigenomics AG: Full Year Results for the Year Ended 31 December 2010
Continuing to build European market and expanding beyond. Focus 2010/2011 on U.S. product development and FDA submission. Launch of Epi proColon® 2.0 in Europe planned for 2011 Contact: Dr. Achim Plum Sen. VP Corporate Development Epigenomics AG Tel: +49 30 24345 368 achim.plum@epigenomics.com Branche: Biotechnology ISIN: DE000A0BVT96 WKN: A0BVT9 Index: ...